European Radiology

, Volume 18, Issue 4, pp 753–758 | Cite as

Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice

  • Manfred Jugold
  • Moritz Palmowski
  • Jochen Huppert
  • Eva C. Woenne
  • Margareta M. Mueller
  • Wolfhard Semmler
  • Fabian Kiessling
Molecular Imaging


The sensitivity of Doppler ultrasound below 10 MHz to assess antiangiogenic therapy effects in tumor xenografts has been shown to be limited. Thus, our aim was to evaluate high-frequency volumetric power-Doppler ultrasound (HF-VPDU) for monitoring antiangiogenic treatments. Squamous cell carcinoma xenografts grown in nude mice were scanned with HF-VPDU at a center frequency of 30 MHz. Images with 200-μm slice thicknesses were recorded and merged into a three-dimensional dataset, of which the relative color pixel density was determined. Animals received either VEGFR2 antibodies or 0.9% NaCl and were examined at days 0, 3 and 6 of treatment. After the last examination, tumors were resected and their vascularization characterized by immunohistology. At day 6, the volumes of treated and untreated tumors were not significantly different yet. In contrast, mean tumor vascularization in treated animals had decreased to 44%, while in the control group it had increased to 152% (P < 0.01). In correspondence, vessel density, as determined by CD31 staining, was 0.19 ± 0.10% in treated and 0.92 ± 0.41% in untreated tumors (P < 0.01). Additionally, the fraction of mature (SMA-positive) vessels increased under therapy. Thus, HF-VPDU can be considered as an easily applicable and fast method to screen high animal numbers for antiangiogenic therapy effects.


Angiogenesis Tumor therapy Ultrasound High frequency Power Doppler 



This work was supported by the transregional grant Vascular differentiation and remodeling from the German Research Foundation (DFG, SFB-TR23).


  1. 1.
    Folkman J (2006) Angiogenesis. Annu Rev Med 57:1–18PubMedCrossRefGoogle Scholar
  2. 2.
    Folkman J (2003) Angiogenesis inhibitors: a new class of drugs. Cancer Biol Ther 2:127–133Google Scholar
  3. 3.
    Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 15:967–974CrossRefGoogle Scholar
  4. 4.
    Kiessling F, Farhan N, Lichy MP, Vosseler S, Heilmann M, Krix M, Bohlen P, Miller DW, Mueller MM, Semmler W, Fusenig NE, Delorme S (2004) Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia 6:213–223PubMedCrossRefGoogle Scholar
  5. 5.
    Fleischer AC, Niermann KJ, Donnelly EF, Yankeelov TE, Canniff KM, Hallahan DE, Rothenberg ME (2004) Sonographic depiction of microvessel perfusion: principles and potential. J Ultrasound Med 23:1499–1506PubMedGoogle Scholar
  6. 6.
    Neeman M, Gilad AA, Dafni H, Cohen B (2007) Molecular imaging of angiogenesis. J Magn Reson Imaging 25:1–12PubMedCrossRefGoogle Scholar
  7. 7.
    Fleischer AC, Milam MR, Crispens MA, Shappell HW (2005) Sonographic depiction of intratumoral vascularity with 2- and 3-dimensional color Doppler techniques. J Ultrasound Med 24:533–537PubMedGoogle Scholar
  8. 8.
    Krix M, Kiessling F, Vosseler S, Farhan N, Mueller MM, Bohlen P, Fusenig NE, Delorme S (2003) Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res 63:8264–8270PubMedGoogle Scholar
  9. 9.
    Lee TY, Purdie TG, Stewart E (2003) CT imaging of angiogenesis. Q J Nucl Med 47:171–187PubMedGoogle Scholar
  10. 10.
    Laking GR, Price PM (2003) Positron emission tomographic imaging of angiogenesis and vascular function. Br J Radiol 76:50–59CrossRefGoogle Scholar
  11. 11.
    Delorme S, Krix M (2006) Contrast-enhanced ultrasound for examining tumor biology. Cancer Imaging 6:148–152PubMedCrossRefGoogle Scholar
  12. 12.
    Lindner JR (2004) Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 3:527–532PubMedCrossRefGoogle Scholar
  13. 13.
    Qin S, Ferrara KW (2006) Acoustic response of compliable microvessels containing ultrasound contrast agents. Phys Med Biol 51:5065–5088PubMedCrossRefGoogle Scholar
  14. 14.
    Goertz DE, Christopher DA, Yu JL, Kerbel RS, Burns PN, Foster FS (2000) High-frequency color flow imaging of the microcirculation. Ultrasound Med Biol 26:63–71PubMedCrossRefGoogle Scholar
  15. 15.
    Fusenig NE, Boukamp P (1998) Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. J Mol Carcinogenesis 23:144–158CrossRefGoogle Scholar
  16. 16.
    Mueller MM, Peter W, Mappes M, Huelsen A, Steinbauer H, Boukamp P, Vaccariello M, Garlick J, Fusenig NE (2001) Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 159:1567–1579PubMedGoogle Scholar
  17. 17.
    Gee MS, Saunders HM, Lee JC, Sanzo JF, Jenkins WT, Evans SM, Trinchieri G, Sehgal CM, Feldman MD, Lee WM (2001) Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 61:2974–2982PubMedGoogle Scholar
  18. 18.
    Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS (2002) High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 62:6371–6375PubMedGoogle Scholar
  19. 19.
    Rubin JM, Fowlkes JB, Tuthill TA, Moskalik AP, Rhee RT, Adler RS, Kazanjian SN, Carson PL (1999) Speckle decorrelation flow measurement with B-mode US of contrast agent flow in a phantom and in rabbit kidney. Radiology 213:429–437PubMedGoogle Scholar
  20. 20.
    Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, Jain RK (2001) In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 7:864–868PubMedCrossRefGoogle Scholar
  21. 21.
    Cheung AM, Brown AS, Cucevic V, Roy M, Needles A, Yang V, Hicklin DJ, Kerbel RS, Foster FS (2007) Detecting vascular changes in tumor xenografts using micro-ultrasound and micro-ct following treatment with VEGFR-2 blocking antibodies. Ultrasound Med Biol 8:1259–1268CrossRefGoogle Scholar
  22. 22.
    Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685–693PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2007

Authors and Affiliations

  • Manfred Jugold
    • 1
    • 2
  • Moritz Palmowski
    • 1
    • 2
    • 3
  • Jochen Huppert
    • 1
    • 2
  • Eva C. Woenne
    • 1
    • 2
  • Margareta M. Mueller
    • 4
  • Wolfhard Semmler
    • 2
  • Fabian Kiessling
    • 1
    • 2
  1. 1.Junior Group Molecular ImagingGerman Cancer Research CenterHeidelbergGermany
  2. 2.Department of Medical Physics in RadiologyGerman Cancer Research CenterHeidelbergGermany
  3. 3.Department of Diagnostic RadiologyUniversity of HeidelbergHeidelbergGermany
  4. 4.Group Tumor and MicroenvironmentGerman Cancer Research CenterHeidelbergGermany

Personalised recommendations